Πωλήσεις 46 δισ. δολαρίων πραγματοποίησαν οι 10 μεγαλύτερες εταιρείες γενοσήμων στον κόσμο

Πωλήσεις 46 δισ. δολαρίων πραγματοποίησαν οι 10 μεγαλύτερες εταιρείες γενοσήμων στον κόσμο

Teva Scraps A Study In Cluster Headaches — And This Rival Benefits

Alder Biopharmaceuticals (ALDR) stock gapped up Friday after rival Teva Pharmaceutical (TEVA) scrapped a late-stage study of its anti-CGRP migraine prevention drug in chronic cluster headaches.   At the closing bell on the stock market today, Alder popped 6.7%, to 17.65. Shares of Teva dipped a fraction, to 23.76. Rival Eli Lilly (LLY) rose a … Συνεχίστε να διαβάζετε Teva Scraps A Study In Cluster Headaches — And This Rival Benefits.

Teva launches chronic disease patient website Life Effects

Teva Pharmaceuticals has rolled out the latest part of its rebranding push: Life Effects, a patient-centric website for chronic diseases.   The portal features patient stories and tips for dealing with four chronic diseases: ADHD, depression, asthma, and migraines. Teva's goal is to go beyond the medicine and side effects and instead explore the “life … Συνεχίστε να διαβάζετε Teva launches chronic disease patient website Life Effects.